Guardant Health (GH) CMO nets shares as RSUs vest and taxes withheld

Rhea-AI Filing Summary

Guardant Health, Inc. Chief Medical Officer Craig Eagle reported routine equity compensation activity as several restricted stock unit awards vested on April 1, 2026. He exercised RSUs to acquire a total of 11,400 shares of common stock at an exercise price of $0.00 per share.

To satisfy related tax obligations, 5,779 shares of common stock were retained by the company at $91.15 per share, as described in the footnotes, rather than sold on the open market. Following these transactions, Eagle directly holds 72,001 shares of Guardant Health common stock.

Insider Trade Summary

11,400 shares exercised/converted

Mixed 9 txns

Insider EAGLE CRAIG

Role Chief Medical Officer

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Units	1,714	$0.00	--
Exercise	Restricted Stock Units	1,667	$0.00	--
Exercise	Restricted Stock Units	2,660	$0.00	--
Exercise	Restricted Stock Units	5,359	$0.00	--
Exercise	Common Stock	1,714	$0.00	--
Exercise	Common Stock	1,667	$0.00	--
Exercise	Common Stock	2,660	$0.00	--
Exercise	Common Stock	5,359	$0.00	--
Tax Withholding	Common Stock	5,779	$91.15	$527K

Holdings After Transaction: Restricted Stock Units — 3,429 shares (Direct); Common Stock — 68,094 shares (Direct)

Footnotes (1)

1. These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. This represents a restricted stock unit award granted on November 7, 2022 that vests over a four-year period. 25% of the shares subject to such award vested on October 1, 2023 and the remaining 75% of the shares vests in equal quarterly installments over the remaining three-year period thereafter. Not applicable for Restricted Stock Units. This represents a restricted stock unit award granted on December 13, 2023 that vests over a three-year period. 33% of the shares subject to such award vested on October 1, 2024 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter. This represents a restricted stock unit award granted on November 8, 2024 that vests over a three-year period. 33% of the shares subject to such award vested on October 1, 2025 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter. This represents a restricted stock unit award granted on March 12, 2025 that vests over a three-year period. 33% of the shares subject to such award vested on April 1, 2026 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter.

Key Figures

RSUs exercised: 11,400 shares Tax withholding shares: 5,779 shares Withholding price: $91.15 per share +1 more

4 metrics

RSUs exercised 11,400 shares Total RSU shares converted to common stock on April 1, 2026

Tax withholding shares 5,779 shares Common stock retained by company to meet tax obligations

Withholding price $91.15 per share Value used for shares retained for tax withholding

Post-transaction holdings 72,001 shares Common stock directly held by Craig Eagle after all entries

Key Terms

Restricted Stock Units, restricted stock unit award, vests in equal quarterly installments, tax withholding obligations, +1 more

5 terms

Restricted Stock Units financial

"These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units."

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

restricted stock unit award financial

"This represents a restricted stock unit award granted on November 7, 2022 that vests over a four-year period."

A restricted stock unit award is a promise by a company to give an employee a specified number of company shares at a future date if certain conditions are met, such as staying with the company or hitting performance goals. For investors, these awards matter because they can increase the total number of shares outstanding when converted, diluting existing holders, and they align employees’ incentives with shareholders’ interests much like giving a rising bonus that becomes real only after conditions are satisfied.

vests in equal quarterly installments financial

"the remaining 75% of the shares vests in equal quarterly installments over the remaining three-year period thereafter."

tax withholding obligations financial

"These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder"

tax-withholding disposition financial

"transaction_action": "tax-withholding disposition""

A tax-withholding disposition is an event or transaction—such as selling or transferring securities, exercising options, or receiving compensation—that triggers a requirement to hold back part of the payment and remit it to tax authorities. It matters to investors because it reduces the cash they receive immediately and can change the timing and amount of taxable income, like a cashier taking a portion of your sale proceeds to pay taxes before you get the rest.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

EAGLE CRAIG

(Last) (First) (Middle)

3100 HANOVER STREET

(Street)

PALO ALTO CALIFORNIA 94304

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Guardant Health, Inc. [ GH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Medical Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	04/01/2026		M		1,714	A	$0	68,094	D
Common Stock	04/01/2026		M		1,667	A	$0	69,761	D
Common Stock	04/01/2026		M		2,660	A	$0	72,421	D
Common Stock	04/01/2026		M		5,359	A	$0	77,780	D
Common Stock	04/01/2026		F		5,779(1)	D	$91.15	72,001	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	$0	04/01/2026		M			1,714	(2)	(3)	Common Stock	1,714	$0	3,429	D
Restricted Stock Units	$0	04/01/2026		M			1,667	(4)	(3)	Common Stock	1,667	$0	3,335	D
Restricted Stock Units	$0	04/01/2026		M			2,660	(5)	(3)	Common Stock	2,660	$0	15,955	D
Restricted Stock Units	$0	04/01/2026		M			5,359	(6)	(3)	Common Stock	5,359	$0	10,883	D

Explanation of Responses:

1. These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability.

2. This represents a restricted stock unit award granted on November 7, 2022 that vests over a four-year period. 25% of the shares subject to such award vested on October 1, 2023 and the remaining 75% of the shares vests in equal quarterly installments over the remaining three-year period thereafter.

3. Not applicable for Restricted Stock Units.

4. This represents a restricted stock unit award granted on December 13, 2023 that vests over a three-year period. 33% of the shares subject to such award vested on October 1, 2024 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter.

5. This represents a restricted stock unit award granted on November 8, 2024 that vests over a three-year period. 33% of the shares subject to such award vested on October 1, 2025 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter.

6. This represents a restricted stock unit award granted on March 12, 2025 that vests over a three-year period. 33% of the shares subject to such award vested on April 1, 2026 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter.

Remarks:

	/s/ John G. Saia, as attorney-in-fact for Craig Eagle	04/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did Guardant Health (GH) Chief Medical Officer Craig Eagle report on this Form 4?

Craig Eagle reported routine equity compensation activity. Several restricted stock unit awards vested and were converted into common shares, and a portion of those shares was withheld by Guardant Health to cover tax obligations associated with the vesting, as is common for RSU awards.

How many Guardant Health (GH) shares did Craig Eagle acquire through RSU vesting?

Craig Eagle acquired 11,400 shares of Guardant Health common stock through the vesting and exercise of restricted stock units. The Form 4 shows multiple RSU tranches converting into common shares on April 1, 2026 as part of previously granted long-term incentive awards.

How many Guardant Health (GH) shares were withheld for taxes in this filing?

Guardant Health retained 5,779 shares of common stock to cover Craig Eagle’s tax withholding obligations. The footnote explains these shares were withheld in connection with RSU vesting and were not in excess of the related tax liability for the award-holder’s obligations.

How many Guardant Health (GH) shares does Craig Eagle hold after these transactions?

After the reported RSU vesting and tax withholding, Craig Eagle directly holds 72,001 shares of Guardant Health common stock. This post-transaction holding figure comes from the Form 4 totals shown for his common stock position following all entries on April 1, 2026.

Were Craig Eagle’s Guardant Health (GH) transactions open-market stock sales or purchases?

The transactions were not open-market trades. They reflect RSU vesting and related share issuance, plus shares retained by Guardant Health to satisfy tax withholding. The code F entry is a tax-withholding disposition, not a discretionary sale in the open market.

What do the RSU vesting schedules in Craig Eagle’s Guardant Health (GH) awards show?

Footnotes describe RSU awards granted in 2022, 2023, 2024, and 2025 with three- or four-year schedules. Initial portions vested on specific dates, such as October 1, 2023, with remaining shares vesting in equal quarterly installments over the stated multi-year periods thereafter.